Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 2009

View Archived Issues

Rosuvastatin reduces high sensitivity C-reactive protein and LDLC

Effects of bivalirudin in HORIZONS-AMI trial independent of clopidogrel dose

Novel MEK inhibitors identified by Curis

Abbott describes novel prodrugs of a histamine H3 receptor ligand

T-type calcium channel inhibitors claimed by Ewha Womans University as analgesics

Boehringer Ingelheim claims novel calcitonin gene-related peptide antagonists

Arete Therapeutics presents epoxide hydrolase inhibitors for the treatment of hypertension

First human pharmacokinetic data for anticancer agent KP-1019 reported

Merck & Co. and Santen enter licensing agreement for tafluprost

Pro-Pharmaceuticals' Davanat was not associated with mucositis in phase I and II trials

Pfizer and Medivation initiate phase III trial of Dimebon added to donepezil in AD patients

Novel corticotropin-releasing factor receptor antagonists developed as anxiolytics

Cannasat and IntelGenx report phase Ib results for buccal dronabinol

Etanercept to be studied in Kawasaki disease / News in Context

Infinity stops RING trial in advanced GIST, clinical trials to continue in other cancers

Novagali completes phase II Cyclokat trial in dry eye

Vyteris and Zealand Pharma sign collaboration agreement in transdermal peptide delivery

Tekmira files IND with FDA for phase I clinical trial of ApoB SNALP for LDL cholesterol

Asahi Kasei and Dong-A sign license agreement for BPH drug Flivas

XenoPort exercises co-promotion option contained in agreement with GSK for Solzira

Accera forms wholly owned subsidiary, Neuera Pharmaceuticals

Sirion reports interim phase II results for fenretinide

Ensemble forms alliance with Bristol-Myers Squibb to develop novel drug class

Cangene to supply the U.S. Department of Defense with VIG vaccine

Clinuvel provides update on afamelanotide

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...